BODI

AI Memo

Beachbody

As of 2026-05-19/Confidence medium

Open ticker Back to Memos

Data freshness

AI Memo

As of 2026-05-19 • Model: RankAlpha Sentiment Codex

Decision Panel

Action, confidence, horizon, and decision blockers at a glance.

Action

—

Confidence

medium

Horizon

—

Key catalyst

Q1 print beat guidance while confirming third straight quarter of profitability • 2026-05-12

Expected move: -4%

Biggest risk

Revenue fell 25% year over year, digital subscriptions dropped to 0.81M, nutritional subscriptions fell to 0.06M, and Q2 revenue guidance still implies a much smaller business. Without evidence of sustained retail demand, profitability may plateau.

Invalidation

Break below $6 or thesis failure.

What would change my mind?

Q1 confirmed a profitable operating model, gross margin held at 71.8%, and management says it has the balance-sheet flexibility to fund retail expansion. If Shakeology and later P90X/INSANITY retail sell-through is real, the nutrition mix could extend the turnaround.

Research note

Recommendation

—

Confidence

medium

As of

2026-05-19

Base target

$11

p=50%

Bull target

$14

p=20%

Bear target

p=30%

Key bullets

Fast scan of bull, bear, and watch items

BullKey bullets

Q2 guide implies profitability but a still-smaller revenue base
Retail distribution could broaden the nutrition franchise beyond direct-to-consumer
Q1 confirmed a profitable operating model, gross margin held at 71.8%, and management says it has the balance-sheet flexibility to fund retail expansion.

BearKey bullets

Digital subscriptions were 0.81M and nutritional subscriptions were 0.06M; retention and streams also softened, showing engagement is not yet back to prior levels.
Q1 revenue was down 25% year over year and total subscriptions fell 20.9%, so the recovery still depends on new products and channel mix.
Q2 guidance of $46M-$51M revenue and $3M-$6M adjusted EBITDA suggests only modest quarterly profitability, leaving little cushion if demand or promotion weakens.

WatchKey bullets

Q1 print beat guidance while confirming third straight quarter of profitability

Summary

High-level snapshot

Recommendation

Model confidence

medium

Timeframe

Asset

Equity

Trigger

Base case: $11 (p=50%)

Bull/Bear spread: +28% / -45%

Vs latest close: Bull +28% · Base -4% · Bear -45%

Scenario probabilities

Bull Target: $14 (p=20%)Base Target: $11 (p=50%)Bear Target: $6 (p=30%)

Commentary

Primary-source coverage is strong but narrow: the packet includes the Q1 release and the 10-K, but no post-print analyst revisions or credible social read-through. The print was meaningfully better on profitability, yet the sharp revenue and subscription decline keeps conviction cautious. The latest anchor price of $10.17 is below the packet’s sparse median target of $11.38, but that target is thin and should not overpower the weakening top line.

As of 2026-05-19 • Updated bi-weekly / post-earningsSource: Internal modelMethodology

Analyst Summary

Thesis highlights from the latest analysis

Bull Case

Bear Case

Drivers

Scannable catalysts and supporting factors

Q2 guide implies profitability but a still-smaller revenue base
Retail distribution could broaden the nutrition franchise beyond direct-to-consumer

Scenarios

Bull Target (Scenario probability)

$14 / p=20% prob

Base Target (Scenario probability)

$11 / p=50% prob

Bear Target (Scenario probability)

$6 / p=30% prob

Price $11 as of 2026-05-29

Nearest Scenario: Base (∆ 4%)

Targets vs latest close: Bull +28% · Base -4% · Bear -45%

Sentiment & Exposure

News Sentiment (30d)

0.62

Social Sentiment (7d)

0.00

Events

Other notable items detected

EVENT2026-05-12
Q1 print beat guidance while confirming third straight quarter of profitability
The May 12 release reported Q1 revenue of $54.3M, operating income of $3.1M, net income of $2.3M, and adjusted EBITDA of $8.0M, and management said revenue, net income, and adjusted EBITDA all exceeded the high end of guidance. That supports the turnaround narrative, but the top line still fell 25% year over year and subscriptions declined. [#8-K-2026-05-12]
Prob 95.00% • Move 6.00% • Priced-in 65.00%

Short-term Catalysts

Next few weeks

Q2 guide implies profitability but a still-smaller revenue base
2026-06-30
Management guided Q2 revenue to $46M-$51M and adjusted EBITDA to $3M-$6M, which shows the business can stay profitable but also implies a materially smaller top line than last year. That can cap upside if investors focus on the revenue reset rather than the earnings beat. [#8-K-2026-05-12]
Prob 75% • Move -7% • Priced-in 70%

Long-term Catalysts

Months to a year

Retail distribution could broaden the nutrition franchise beyond direct-to-consumer
2026-12-31
The 2025 10-K said the company planned to sell Shakeology in retail for the first time in 2026 and later roll out P90X and INSANITY supplements; the Q1 release reiterated that retail expansion and the nutrition platform are central to the growth plan. If execution holds, wider distribution could broaden the addressable market and improve mix. [#10-K-2026-03-10]
Prob 60% • Move 18% • Priced-in 55%

Risks

Digital subscriptions were 0.81M and nutritional subscriptions were 0.06M; retention and streams also softened, showing engagement is not yet back to prior levels.
Q1 revenue was down 25% year over year and total subscriptions fell 20.9%, so the recovery still depends on new products and channel mix.
Q2 guidance of $46M-$51M revenue and $3M-$6M adjusted EBITDA suggests only modest quarterly profitability, leaving little cushion if demand or promotion weakens.
The retail rollout and innovation pipeline are execution-dependent; weak channel uptake or slower sell-through would pressure the thesis.

Peers

Symbol	Summary
NDLS	Adjacent small-cap consumer-services reference for turnaround, traffic, and margin sensitivity; not a true nutrition or digital-fitness peer.
GENK	Another tiny consumer-services name that is useful mainly as a scale and volatility comparator rather than an operating comp.
RGS	Consumer-services turnaround comparator with execution sensitivity, though the business mix is very different.

Sources

Internal and external references used in this analysis

Model source: RankAlpha Sentiment Codex
Analysis date: 2026-05-19

AI Stock Memo: BODI - Beachbody - RankAlpha